Guardant Health (GH) Competitors $42.87 -4.53 (-9.56%) Closing price 04:00 PM EasternExtended Trading$43.12 +0.25 (+0.57%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends GH vs. NTRA, FMS, HIMS, OPCH, RDNT, BTSG, SHC, SGRY, VCYT, and LFSTShould you be buying Guardant Health stock or one of its competitors? The main competitors of Guardant Health include Natera (NTRA), Fresenius Medical Care (FMS), Hims & Hers Health (HIMS), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Veracyte (VCYT), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry. Guardant Health vs. Natera Fresenius Medical Care Hims & Hers Health Option Care Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Veracyte LifeStance Health Group Guardant Health (NASDAQ:GH) and Natera (NASDAQ:NTRA) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability. Does the MarketBeat Community believe in GH or NTRA? Natera received 196 more outperform votes than Guardant Health when rated by MarketBeat users. However, 70.59% of users gave Guardant Health an outperform vote while only 69.04% of users gave Natera an outperform vote. CompanyUnderperformOutperformGuardant HealthOutperform Votes28870.59% Underperform Votes12029.41% NateraOutperform Votes48469.04% Underperform Votes21730.96% Is GH or NTRA more profitable? Natera has a net margin of -14.01% compared to Guardant Health's net margin of -74.02%. Natera's return on equity of -26.23% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Guardant Health-74.02% -1,200.44% -29.88% Natera -14.01%-26.23%-14.27% Do analysts recommend GH or NTRA? Guardant Health currently has a consensus target price of $44.78, indicating a potential upside of 4.45%. Natera has a consensus target price of $170.94, indicating a potential upside of 5.32%. Given Natera's higher probable upside, analysts plainly believe Natera is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 0 Sell rating(s) 0 Hold rating(s) 18 Buy rating(s) 0 Strong Buy rating(s) 3.00Natera 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer GH or NTRA? In the previous week, Guardant Health had 8 more articles in the media than Natera. MarketBeat recorded 21 mentions for Guardant Health and 13 mentions for Natera. Natera's average media sentiment score of 1.35 beat Guardant Health's score of 0.54 indicating that Natera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 6 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive Natera 10 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, GH or NTRA? Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$563.95M9.39-$479.45M-$4.24-10.11Natera$1.08B19.79-$434.80M-$1.76-92.22 Do institutionals & insiders hold more shares of GH or NTRA? 92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 5.5% of Guardant Health shares are owned by company insiders. Comparatively, 7.6% of Natera shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more risk & volatility, GH or NTRA? Guardant Health has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, Natera has a beta of 1.66, meaning that its share price is 66% more volatile than the S&P 500. SummaryNatera beats Guardant Health on 13 of the 17 factors compared between the two stocks. Get Guardant Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GH vs. The Competition Export to ExcelMetricGuardant HealthMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.30B$3.11B$5.78B$8.98BDividend YieldN/A20.51%4.78%3.85%P/E Ratio-10.1115.6226.4618.82Price / Sales9.39173.07457.0180.76Price / CashN/A387.2444.0437.47Price / Book31.994.847.634.64Net Income-$479.45M-$22.21M$3.18B$245.69M7 Day Performance-10.91%-4.33%-1.82%-2.63%1 Month Performance-5.01%-0.84%0.22%-2.37%1 Year Performance89.19%13.18%17.49%13.65% Guardant Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GHGuardant Health4.2444 of 5 stars$42.87-9.6%$44.78+4.5%+107.6%$5.30B$563.95M-10.111,779Earnings ReportAnalyst ForecastNews CoverageHigh Trading VolumeNTRANatera2.5737 of 5 stars$173.39+1.6%$165.88-4.3%+138.9%$22.89B$1.08B-98.523,293Positive NewsFMSFresenius Medical Care4.0035 of 5 stars$23.46-3.3%$25.30+7.9%+11.2%$13.76B$21.05B19.381,358Positive NewsGap DownHIMSHims & Hers Health2.6372 of 5 stars$60.41+2.1%$25.13-58.4%+589.7%$13.20B$872M137.311,046Analyst DowngradeInsider TradeNews CoverageGap DownHigh Trading VolumeOPCHOption Care Health4.0267 of 5 stars$31.46-1.1%$32.25+2.5%-3.2%$5.35B$4.30B26.447,802Positive NewsRDNTRadNet3.9248 of 5 stars$61.33-1.9%$75.50+23.1%+66.2%$4.54B$1.62B-876.0210,288BTSGBrightSpring Health Services1.8058 of 5 stars$22.05-0.1%$19.42-11.9%+95.6%$3.84B$10.59B-84.8135,000SHCSotera Health2.1614 of 5 stars$13.48+0.4%$16.08+19.3%-16.8%$3.82B$1.05B53.923,000Analyst ForecastNegative NewsSGRYSurgery Partners3.081 of 5 stars$25.87+0.3%$36.56+41.3%-23.9%$3.29B$2.74B-53.9013,500VCYTVeracyte2.9112 of 5 stars$41.11+3.8%$42.00+2.2%+64.0%$3.19B$361.05M-274.07790Analyst DowngradeNews CoverageLFSTLifeStance Health Group1.5336 of 5 stars$7.97-0.3%$8.70+9.2%+18.5%$3.05B$1.21B-30.659,325Upcoming EarningsNews Coverage Related Companies and Tools Related Companies Natera Alternatives Fresenius Medical Care Alternatives Hims & Hers Health Alternatives Option Care Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Surgery Partners Alternatives Veracyte Alternatives LifeStance Health Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GH) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardant Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardant Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
